These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 4784043)

  • 21. [Chemotherapeutic activity of isonicotinoyl hydrazide of phosphonacetic acid in experimental tuberculosis].
    Berim MG; Gozman EA; Kalugina NM
    Probl Tuberk; 1978 Nov; (11):79-82. PubMed ID: 724701
    [No Abstract]   [Full Text] [Related]  

  • 22. [Examination of a combination ointment containing anabolic and catabolic local steroids on the experimental acanthosis of the guinea pig].
    Heite HJ; Cardona F
    Arzneimittelforschung; 1973 Oct; 23(10):1473-7. PubMed ID: 4801332
    [No Abstract]   [Full Text] [Related]  

  • 23. [Experimental substantiation of immunomodulating therapy with sodium nucleinate in tuberculosis].
    Cernuşenko EF; Ciumak AA
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1984; 33(2):143-50. PubMed ID: 6093221
    [No Abstract]   [Full Text] [Related]  

  • 24. [Histochemical characteristics of changes in organs of guinea pigs infected with different strains of Mycobacterium tuberculosis].
    Beliakova OI
    Probl Tuberk; 1967; 45(2):77-81. PubMed ID: 4236795
    [No Abstract]   [Full Text] [Related]  

  • 25. [Use of anabolic steroids in therapy].
    Fossati C
    Clin Ter; 1974 Jul; 70(2):169-202. PubMed ID: 4212873
    [No Abstract]   [Full Text] [Related]  

  • 26. [Effect of isoniazid and of a complex compound of cobalt with pyridoxine on rabbits infected with tuberculosis].
    Sodikov ES; Gapon'ko LA
    Farmakol Toksikol; 1972; 35(2):234-7. PubMed ID: 5017977
    [No Abstract]   [Full Text] [Related]  

  • 27. [Therapeutic properties of a prolonged-action preparation of isoniazid].
    Ivaniuta OM; Maliuk VI; Sokirko TA; Klimenko MT; Suslov EI
    Probl Tuberk; 1988; (3):47-50. PubMed ID: 3387395
    [No Abstract]   [Full Text] [Related]  

  • 28. [Preliminary study on isoniazid-epiroprim combination in a tuberculosis murine model].
    N'guessan K; Dosso M; Marchal G; Chavarot P; Romain F; Pescher P; Edy
    Bull Soc Pathol Exot; 2002 Nov; 95(4):265-8. PubMed ID: 12596375
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Surface-active properties of pulmonary surfactant in experimental pulmonary tuberculosis].
    Bondarev IM; Agapov IuIa; Volkova NV
    Ter Arkh; 1975; 47(1):109-10. PubMed ID: 1172889
    [No Abstract]   [Full Text] [Related]  

  • 30. Durable cure for tuberculosis: rifalazil in combination with isoniazid in a murine model of Mycobacterium tuberculosis infection.
    Shoen CM; DeStefano MS; Cynamon MH
    Clin Infect Dis; 2000 Jun; 30 Suppl 3():S288-90. PubMed ID: 10875802
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Isoniazid pharmacokinetics in the combined chemotherapy of tuberculosis].
    Sokolova GB; Vilenskaia RN; Ivleva AIa; Galenko NN; Ziia AV
    Probl Tuberk; 1981 Oct; (10):24-8. PubMed ID: 7312844
    [No Abstract]   [Full Text] [Related]  

  • 32. [Mechanisms of anti-inflammatory activity of antioxidants in lung tuberculosis].
    Andrzheiuk NI; Kruglova EG; Novosëlova VP
    Probl Tuberk; 1994; (2):49-53. PubMed ID: 8036223
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effectiveness of the rapid intravenous administration of rifampicin and isoniazid and of the intramuscular administration of streptomycin in disseminated destructive pulmonary tuberculosis in dogs].
    Bondarev IM; Ivanov VL; Novoselova VP; Kovaleva LA; Shtegel'man LA
    Antibiotiki; 1984 Jun; 29(6):430-4. PubMed ID: 6476805
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Methandienone in pulmonary tuberculosis.
    Bhatia JL; Raj B
    J Indian Med Assoc; 1966 Aug; 47(4):176-8. PubMed ID: 5911066
    [No Abstract]   [Full Text] [Related]  

  • 35. [Effect of tuberculostatic preparations on carbohydrate-phosphorus metabolism in the liver and lungs of animals with tuberculosis].
    Kharakter ZhZ
    Vopr Med Khim; 1968; 14(6):601-6. PubMed ID: 5753642
    [No Abstract]   [Full Text] [Related]  

  • 36. Conversion by isoniazid of hyperacute to chronic pulmonary tuberculosis in mice. II. Histopathology of lungs.
    Mayer E; Salamandra IA
    Am Rev Respir Dis; 1967 Aug; 96(2):220-8. PubMed ID: 4951907
    [No Abstract]   [Full Text] [Related]  

  • 37. [Morphological changes of internal organs during treatment of tuberculosis with proteolytic enzymes].
    Shlapak PT; Shvartsman LI
    Probl Tuberk; 1972; 50(4):79-83. PubMed ID: 5019370
    [No Abstract]   [Full Text] [Related]  

  • 38. [Anabolic steroids in the treatment of liver diseases].
    Mossor-Ostrowska J
    Pol Tyg Lek; 1971 Aug; 26(32):1248-51. PubMed ID: 4942579
    [No Abstract]   [Full Text] [Related]  

  • 39. Oral solid lipid nanoparticle-based antitubercular chemotherapy.
    Pandey R; Sharma S; Khuller GK
    Tuberculosis (Edinb); 2005; 85(5-6):415-20. PubMed ID: 16256437
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Outpatient management of tuberculosis.
    McColloster P; Neff NE
    Am Fam Physician; 1996 Apr; 53(5):1579-94. PubMed ID: 8623687
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.